| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/16/2001 | EP1123092A2 Fumaric acid microtablets |
| 08/16/2001 | EP1123091A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 08/16/2001 | EP1123086A2 Artificial antigen-specific cells and related methods |
| 08/16/2001 | EP0765329B1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 08/16/2001 | EP0694307B1 Atopic disease remedy |
| 08/16/2001 | EP0688330B1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 08/16/2001 | EP0558677B1 Biologically active amines |
| 08/16/2001 | EP0552256B1 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 08/16/2001 | DE10006453A1 New piperidylcarboxylic acid derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological diseases, e.g. atherosclerosis, asthma, diabetes, rheumatoid arthritis or transplant rejection |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2416343A1 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | CA2400488A1 Methods for the prevention and treatment of infections using anti-c3b(i) antibodies |
| 08/16/2001 | CA2400472A1 Il-17 like molecules and uses thereof |
| 08/16/2001 | CA2399969A1 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 08/16/2001 | CA2399944A1 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases |
| 08/16/2001 | CA2399873A1 Drug metabolizing enzymes |
| 08/16/2001 | CA2399800A1 Remedies for sjoegren's syndrome |
| 08/16/2001 | CA2399799A1 2-phenylcarbamoyl-benzimidazoles |
| 08/16/2001 | CA2399623A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399396A1 Tnf- .alpha. inhibitors |
| 08/16/2001 | CA2399391A1 Trade molecules and uses related thereto |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399136A1 1h-imidazopyridine derivatives |
| 08/16/2001 | CA2399019A1 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | CA2398984A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | CA2398923A1 A group of anti-cancer compounds with specific structure and their production method |
| 08/16/2001 | CA2397993A1 Dehydroamino acids |
| 08/16/2001 | CA2397254A1 Interferon-alpha induced genes |
| 08/15/2001 | CN1308679A Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases |
| 08/15/2001 | CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain |
| 08/15/2001 | CN1308637A Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 08/15/2001 | CN1308635A Novel cyclosporin with improved activity profile |
| 08/15/2001 | CN1308632A 'Beta'-carboline compound |
| 08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |
| 08/15/2001 | CN1308611A Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 08/15/2001 | CN1308609A Method of locking 1 & alpha, -OH of vitamin d compounds in axial orientation |
| 08/15/2001 | CN1308546A Immunomodulators for vaccines |
| 08/15/2001 | CN1308537A Steroid-containing cataplasms and process for producing the same |
| 08/15/2001 | CN1308535A Farnesyl protein transferase inhibitors for treating arthropathies |
| 08/15/2001 | CN1307872A Selenium product of natural marine organism and its preparation |
| 08/15/2001 | CN1307871A Goat fetus essence injecta and its preparation process |
| 08/15/2001 | CN1307867A Mizoribine tablet with improved color |
| 08/14/2001 | US6274718 Porphyromonas gingivalis arginine-specific proteinase coding sequences |
| 08/14/2001 | US6274635 Antitumor agents |
| 08/14/2001 | US6274629 Use for 1,3-propanediol derivatives |
| 08/14/2001 | US6274618 Administering (-)-cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8 -tetrahydronphthalen-2-ol to treat vaginal dryness, itching, or painful intercourse |
| 08/14/2001 | US6274616 ((3-(2-amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2 -methyl-1h-indol-4-yl)oxy)acetic acid n,n-diethylglycolamidoester used for inhibiting human non-pancreatic secretory phopholipase a2 mediated release of |
| 08/14/2001 | US6274589 L-β-dioxolane uridine analogs and their pharmaceutical compositions |
| 08/14/2001 | US6274588 4-phenyl-pyrimidine derivatives |
| 08/14/2001 | US6274577 Autoimmune diseases; antiinflammatory agents |
| 08/14/2001 | US6274572 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
| 08/14/2001 | US6274175 Prolonged release of GM-CSF |
| 08/14/2001 | US6274145 To generate cytolytic t cells against abnormal cells; as markers for pathological or abnormal condition in diagnosis |
| 08/14/2001 | US6274136 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 08/14/2001 | US6274134 Human cell adhesion protein AAMP-1 and uses thereof |
| 08/14/2001 | CA2248955C The use of fumaric acid derivatives |
| 08/14/2001 | CA2243570C Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 08/14/2001 | CA2159640C Second messenger cell signaling inhibitors |
| 08/14/2001 | CA1341285C Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
| 08/10/2001 | WO2000047595A1 Ether type lipid a1-carboxylic acid analogues |
| 08/10/2001 | CA2362246A1 Ether type lipid a1-carboxylic acid analogues |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057233A2 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057226A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | WO2001057175A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057090A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 08/09/2001 | WO2001057085A2 G-protein coupled receptors |
| 08/09/2001 | WO2001057079A2 C1 inhibitor produced in the milk of transgenic mammals |
| 08/09/2001 | WO2001057074A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | WO2001057068A1 Mucin-1 derived antigens and their use in immunotherapy |
| 08/09/2001 | WO2001057060A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | WO2001057042A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/09/2001 | WO2001057036A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057026A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057023A1 Heterocyclic amide derivatives |
| 08/09/2001 | WO2001057022A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | WO2001056993A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001056981A1 Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives |
| 08/09/2001 | WO2001056611A1 Oral delivery of allergens in milk |
| 08/09/2001 | WO2001056603A1 Cd40-binding apc-activating molecules |
| 08/09/2001 | WO2001056602A2 Cd40 ligand adjuvant for respiratory syncytial virus |
| 08/09/2001 | WO2001056601A2 Low dose haptenized tumor cell and tumor cell extract immunotherapy |
| 08/09/2001 | WO2001056598A2 Methods for preventing or attenuating pathoangiogenic conditions by using gbs-toxin (cm101) |
| 08/09/2001 | WO2001056574A1 Use of desloratadine for treating allergic and inflammatory conditions |
| 08/09/2001 | WO2001056571A1 Treating allergic and inflammatory conditions |
| 08/09/2001 | WO2001056562A1 Stable emulsion compositions |
| 08/09/2001 | WO2001056559A1 Aqueous solution for treating degenerative or autoimmune diseases and as immunomodulatory agent |
| 08/09/2001 | WO2001056406A1 Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 08/09/2001 | WO2001056387A1 Immunotherapeutic treatment methodology for patients afflicted with superficial bladder cancer who previously failed at least one immunostimulatory therapeutic treatment regimen |
| 08/09/2001 | WO2001032596A8 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 08/09/2001 | WO2001021796A3 Gl50 molecules and uses therefor |
| 08/09/2001 | WO2001019966A3 Isolation of muscle-derived stem cells and uses therefor |
| 08/09/2001 | WO2001019814A3 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2000075144A8 Peroxynitrite decomposition catalysts and methods of use thereof |